Biological Response Modifiers Advisory Committee
Meeting #35 - Teleconference
June 9, 2003
National Institutes of Health, Building 29A, Room 1A09
1:30 p.m. Welcome and Introductions
Mahendra Rao, M.D., Ph.D., Acting Chair
1:40 Conflict of Interest Meeting Statement
Gail Dapolito, Executive Secretary
1:45 FDA Introductory Remarks
Philip Noguchi, M.D.
Laboratory of Stem Cell Biology
1:50 Steven Bauer, Ph.D.
Laboratory of Immunology and Developmental Biology
2:00 Deborah Hursh, Ph.D.
2:10 Malcolm Moos, M.D., Ph.D.
2:20 Suzanne Epstein, Ph.D.
2:30 Open Public Hearing
3:30 Closed Committee Discussion of Report and Vote
4:30 p.m. Adjourn